As of 2024-12-11, the Fair Value of Neoleukin Therapeutics Inc (NLTX) is -18.23 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.49 USD, the upside of Neoleukin Therapeutics Inc is -622.31%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -31.59 | -69.44 | -33.28 | -60.69 | -57.56 | -50.51 |
| YoY growth | 37.05% | -119.82% | 52.07% | -82.36% | 5.16% | -21.58% |
| Market Cap (mil) | 32.81 |
| P/E | |
| Forward P/E |
| EPS | -3.65 |
| Avg earnings growth rate | -21.58% |
| TTM earnings | -34.27 |